Sponsor:
Ankyra Therapeutics, Inc
Code:
NCT06171750
Conditions
Advanced Solid Tumor
Cutaneous Tumor
Subcutaneous Tumor
Malignant Solid Tumor
Solid Tumor
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
tolododekin alfa
Cemiplimab
Study Details
Eligibility Criteria
Study Design
Interventions and Outcome Measures
Central Contacts and Locations
More Information
Trial information was received from ClinicalTrials.gov and was last updated on 2025-09-18. This information was provided to ClinicalTrials.gov by Ankyra Therapeutics, Inc on 2025-07-18.